Parallel Advisors, LLC Bio Techne Corp Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 2,329 shares of TECH stock, worth $170,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,329

Previous 2,658 12.38%

Holding current value

$170,412

Previous $190,000 2.11%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $23,345 - $27,093	-329 Reduced 12.38%	2,329 $186,000
Q2 2024 Aug 08, 2024	BUY	$62.12 - $84.15 $2,857 - $3,870	46 Added 1.76%	2,658 $190,000
Q1 2024 May 06, 2024	BUY	$65.98 - $77.09 $30,680 - $35,846	465 Added 21.66%	2,612 $183,000
Q4 2023 Feb 09, 2024	BUY	$52.83 - $78.22 $16,060 - $23,778	304 Added 16.49%	2,147 $165,000
Q3 2023 May 20, 2024	SELL	$67.52 - $89.42 $18,365 - $24,322	-272 Reduced 12.86%	1,843 $125,000
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $18,365 - $24,322	-272 Reduced 12.86%	1,843 $125,000
Q2 2023 May 20, 2024	BUY	$73.76 - $85.98 $17,481 - $20,377	237 Added 12.62%	2,115 $172,000
Q2 2023 Aug 04, 2023	BUY	$73.76 - $85.98 $17,481 - $20,377	237 Added 12.62%	2,115 $172,000
Q1 2023 May 20, 2024	SELL	$71.62 - $86.62 $52,569 - $63,579	-734 Reduced 28.1%	1,878 $139,000
Q1 2023 Apr 25, 2023	SELL	$71.62 - $86.62 $62,166 - $75,186	-868 Reduced 31.61%	1,878 $139,000
Q4 2022 Feb 03, 2023	BUY	$80.67 - $352.29 $168,761 - $736,990	2,092 Added 319.88%	2,746 $227,000
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $6,498 - $9,012	-23 Reduced 3.4%	654 $186,000
Q2 2022 Aug 01, 2022	SELL	$322.67 - $449.65 $34,525 - $48,112	-107 Reduced 13.65%	677 $235,000
Q1 2022 Apr 28, 2022	SELL	$353.85 - $487.79 $9,907 - $13,658	-28 Reduced 3.45%	784 $347,000
Q4 2021 Jan 20, 2022	BUY	$456.15 - $525.06 $50,176 - $57,756	110 Added 15.67%	812 $420,000
Q3 2021 Nov 02, 2021	BUY	$444.87 - $538.88 $40,483 - $49,038	91 Added 14.89%	702 $340,000
Q2 2021 Aug 06, 2021	BUY	$387.35 - $450.26 $16,656 - $19,361	43 Added 7.57%	611 $275,000
Q1 2021 Apr 23, 2021	BUY	$314.62 - $411.0 $18,247 - $23,838	58 Added 11.37%	568 $217,000
Q4 2020 Feb 02, 2021	BUY	$246.9 - $321.87 $20,245 - $26,393	82 Added 19.16%	510 $162,000
Q3 2020 Oct 27, 2020	BUY	$232.22 - $282.96 $9,985 - $12,167	43 Added 11.17%	428 $106,000
Q2 2020 Jul 16, 2020	BUY	$185.43 - $279.56 $20,026 - $30,192	108 Added 38.99%	385 $101,000
Q1 2020 Apr 27, 2020	BUY	$161.17 - $221.51 $4,673 - $6,423	29 Added 11.69%	277 $52,000
Q4 2019 Jan 30, 2020	BUY	$189.68 - $222.09 $25,606 - $29,982	135 Added 119.47%	248 $54,000
Q3 2019 Nov 01, 2019	SELL	$183.56 - $216.72 $2,019 - $2,383	-11 Reduced 8.87%	113 $22,000
Q4 2018 Feb 05, 2019	SELL	$132.75 - $203.8 $4,380 - $6,725	-33 Reduced 21.02%	124 $17,000
Q3 2018 Nov 01, 2018	SELL	$147.44 - $204.11 $3,391 - $4,694	-23 Reduced 12.78%	157 $32,000
Q2 2018 Jul 30, 2018	BUY	$144.9 - $165.58 $2,608 - $2,980	18 Added 11.11%	180 $26,000
Q3 2017 Nov 15, 2017	BUY	$113.59 - $123.78 $18,401 - $20,052	162 New	162 $20,000
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $9,314 - $10,149	-82 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	82	82 $10,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Bio Techne Corp Transaction History